Fontaine O, Gore S M, Pierce N F
World Health Organization, Division of Child Health and Development, Via Appia, 1211 - Geneva -27, Switzerland.
Cochrane Database Syst Rev. 2007 Jul 18;1998(4):CD001264. doi: 10.1002/14651858.CD001264.pub2.
Oral rehydration therapy is used to treat dehydration caused by diarrhoea. However the rehydration solution does not reduce stool loss or length of illness. A solution able to do this may lessen the use of ineffective diarrhoea treatments as well as improve morbidity and mortality related to diarrhoea.
The objective of this review was to assess the effects of rice-based oral rehydration salts solution compared with glucose-based oral rehydration salts solution on reduction of stool output and duration of diarrhoea in patients with acute watery diarrhoea.
We searched the Cochrane Infectious Diseases Group trials register, the Cochrane Controlled Trials Register, Medline, Embase, Lilacs and the reference lists of relevant articles. We also contacted researchers in the field.
Randomized trials comparing standard World Health Organization oral rehydration solution with an experimental oral rehydration salts solution in which glucose (20 grams per litre) was replaced by 50-80 grams per litre of rice powder, with the electrolytes remaining unchanged.
Data were extracted independently by a statistician and a clinician.
Twenty-two trials were included. Concealment of allocation was adequate in 15 of these trials. Irrespective of age, people with cholera who were given rice oral rehydration salts solution had substantially lower rates of stool loss than those given oral rehydration salts solution in the first 24 hours. Mean stool outputs in the first 24 hours were lower by 67 millilitres/kg of body weight (weighted mean difference -67.40, 95% confidence interval -94.26 to -41.53) in children, and by 51 millilitres/kg of body weight (weighted mean difference -51.07, 95% confidence interval -65.87 to -36.27) in adults. The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only four millilitres/kg of body weight (weighted mean difference -4.29, 95% confidence interval -9.36 to 0.78).
AUTHORS' CONCLUSIONS: Rice-based oral rehydration appears to be effective in reducing stool output in people with cholera. This effect was not apparent in infants and children with non-cholera diarrhoea.
口服补液疗法用于治疗腹泻引起的脱水。然而,补液溶液并不能减少粪便排出量或缩短病程。一种能够做到这一点的溶液可能会减少无效腹泻治疗方法的使用,并改善与腹泻相关的发病率和死亡率。
本综述的目的是评估与基于葡萄糖的口服补液盐溶液相比,基于大米的口服补液盐溶液对急性水样腹泻患者减少粪便排出量和腹泻持续时间的影响。
我们检索了Cochrane传染病组试验注册库、Cochrane对照试验注册库、Medline、Embase、Lilacs以及相关文章的参考文献列表。我们还联系了该领域的研究人员。
随机试验,比较世界卫生组织标准口服补液溶液与实验性口服补液盐溶液,其中葡萄糖(每升20克)被每升50 - 80克米粉替代,电解质保持不变。
数据由一名统计学家和一名临床医生独立提取。
纳入了22项试验。其中15项试验的分配隐藏充分。无论年龄如何,霍乱患者在前24小时内接受大米口服补液盐溶液时的粪便排出率显著低于接受口服补液盐溶液的患者。儿童在前24小时内的平均粪便排出量每千克体重降低67毫升(加权平均差 - 67.40,95%置信区间 - 94.26至 - 41.53),成人每千克体重降低51毫升(加权平均差 - 51.07,95%置信区间 - 65.87至 - 36.27)。急性非霍乱腹泻婴幼儿和儿童的粪便排出率仅降低每千克体重4毫升(加权平均差 - 4.29,95%置信区间 - 9.36至0.78)。
基于大米的口服补液似乎对减少霍乱患者的粪便排出量有效。这种效果在非霍乱腹泻的婴幼儿和儿童中并不明显。